Keita Ogawa

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Psychological Stress Promotes Tumor Growth in Hepatocellular Carcinoma Models Through Myeloid Signaling.

Psychological Stress Promotes Tumor Growth in Hepatocellular Carcinoma Models Through Myeloid Signaling.

Journal: Cancer science

Published: February 15, 2026

Image Similarity Judgment Method for Waste Printed Circuit Boards.

Image Similarity Judgment Method for Waste Printed Circuit Boards.

Journal: Sensors (Basel, Switzerland)

Published: December 26, 2025

MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma.

MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma.

Journal: Biochemical pharmacology

Published: October 25, 2024

Antibody-Dependent Cellular Cytotoxicity of iPS Cell-Derived Natural Killer T Cells by Anti-GD2 mAb for Neuroblastoma.

Antibody-Dependent Cellular Cytotoxicity of iPS Cell-Derived Natural Killer T Cells by Anti-GD2 mAb for Neuroblastoma.

Journal: Cancer science

Published: June 23, 2024

Anti-tumor effect of intratumoral administration of induced pluripotent stem cell-derived NKT cells on glioblastoma through CD155/DNAM-1 interaction.

Anti-tumor effect of intratumoral administration of induced pluripotent stem cell-derived NKT cells on glioblastoma through CD155/DNAM-1 interaction.

Journal: Stem cells translational medicine

Published: March 06, 2024

Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.

Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.

Journal: Journal of gastroenterology

Published: August 24, 2023

Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.

Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.

Journal: Drugs - real world outcomes

Published: June 19, 2023

Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.

Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.

Journal: Scientific reports

Published: March 24, 2023

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

Journal: Scientific reports

Published: January 08, 2023

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma.

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma.

Journal: World journal of virology

Published: December 28, 2022

Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.

Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.

Journal: Anticancer research

Published: December 06, 2022

Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.

Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.

Journal: Biochemical and biophysical research communications

Published: November 17, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026